Sort by
Refine Your Search
-
(or a related field), is proficient in both mechanistic modeling and ML frameworks (e.g., TensorFlow, PyTorch), and has strong programming skills (Python/MATLAB/C++). Join us to tackle sustainability
-
. - Two-page research statement describing your vision and research plan in the domains of risk and resilience analytics and digital twin modeling, highlighting both technical depth and innovative thinking
-
Scholars are expected to lead analyses critical to the species delimitation research program and to take initiative in contributing to the design of investigations into little brown bats and other species
-
notification and consultation with attending psychologists will be in accordance with the training program's supervision policy, the rules of the Ohio State Psychology Board the Bylaws, Rules and Regulations
-
in the scientific field and accounts for previously unexplained phenomena for new and/or continuing research projects; participate in determining priorities and planning research programs; carry out
-
, and therapeutic response and resistance and to translate these findings to improve patient outcomes. The overall goal of this research program—spanning basic mechanistic discoveries, application of high
-
references, and one or more writing samples (published or in press). Materials should be attached to the application and sent electronically to Dr. Raeshan Davis, Research Scientist and HHMI Program Manager
-
of this research program—spanning basic mechanistic discoveries, application of high-throughput technologies, validation in cancer-relevant mouse models, and translation platforms—is to understand the fundamental
-
– James is the only cancer program in the United States that features a National Cancer Institute (NCI)-designated comprehensive cancer center aligned with a nationally ranked academic medical center and a
-
member of the Oncology Research Information Exchange Network (ORIEN) Robust clinical trials program with active translational therapeutics that include a clinical research unit, Phase 1 U01 grant and N01